ScholarIQanswers from OpenAlex & ORCID
Kenji Kabashima
ResearcherPublications, citations & collaboration network
Kenji Kabashima is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Kenji Kabashima have?
ScholarIQindexed works
Kenji Kabashima has 1,198 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Kenji Kabashima have?
ScholarIQcitation count
Kenji Kabashima has 37,833 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Kenji Kabashima?
ScholarIQh-index
Kenji Kabashima has an h-index of 96 in OpenAlex.
What is the i10-index of Kenji Kabashima?
ScholarIQi10-index
Kenji Kabashima has an i10-index of 432 in OpenAlex.
What is the ORCID of Kenji Kabashima?
ScholarIQorcid
The ORCID for Kenji Kabashima is on the source record.
What is the OpenAlex record for Kenji Kabashima?
ScholarIQopenalex
The OpenAlex for Kenji Kabashima is on the source record.
What are the most-cited papers on Kenji Kabashima?
ScholarIQmost cited works
Atopic dermatitis
Stephan Weidinger, Lisa A. Beck, Thomas Bieber, Kenji Kabashima, Alan D. Irvine
Prostaglandin D <sub>2</sub> as a Mediator of Allergic Asthma
Toshiyuki Matsuoka, Masakazu Hirata, Hiroyuki Tanaka, Yoshimasa Takahashi, Tatsunori Murata, Kenji Kabashima, Yukihiko Sugimoto, Takuya Kobayashi, Fumitaka Ushikubi, Yoshiya Aze, Naomi Eguchi, Yoshihiro Urade, Nobuaki Yoshida, Kazushi Kimura, Akira Mizoguchi, Yoshihito Honda, Hiroichi Nagai, Shuh Narumiya
Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis
Thomas Ruzicka, Jon M. Hanifin, Masutaka Furue, Grażyna Pulka, Izabela Mlynarczyk, Andreas Wollenberg, Ryszard Galus, Takafumi Etoh, Ryosuke Mihara, Hiroki Yoshida, Jonathan Stewart, Kenji Kabashima
Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial
Kristian Reich, Henrique D. Teixeira, Marjolein de Bruin‐Weller, Thomas Bieber, Weily Soong, Kenji Kabashima, Thomas Werfel, Jiewei Zeng, Xiaohong Huang, Xiaofei Hu, Barbara A. Hendrickson, Barry Ladizinski, Alvina D. Chu, Jonathan I. Silverberg
Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase<scp>III</scp>trials
Eric L. Simpson, J.‐P. Lacour, Lynda Spelman, Ricardo Galimberti, Lawrence F. Eichenfield, Robert Bissonnette, Brett King, Jacob P. Thyssen, Jonathan I. Silverberg, Thomas Bieber, Kenji Kabashima, Yuichiro Tsunemi, Antonio Costanzo, Emma Guttman‐Yassky, Lisa A. Beck, Jonathan Janes, Amy M. DeLozier, Margaret Gamalo, Dennis Brinker, T. Cardillo, Fabio P. Nunes, Amy S. Paller, Andreas Wollenberg, Kristian Reich